Latest filing published 06 Oct 2026 for RedHill Biopharma Ltd., €1,262.
Filing timeline
BuySaleInsider track record
Gilead Raday: trading record in brief
Gilead Raday appears in our data through filings on RedHill Biopharma Ltd. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 6 April 2026 and the latest from 1 October 2026.
The open-market record consists of 3 sales worth €3,860, with no purchase.
Most recently, on 6 October 2026, the filings show an open-market sale worth €1,262 in RedHill Biopharma Ltd. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gilead Raday
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,310,000 sharesOrdinary SharesSEC:0001178913-26-004715:0
- 14,130,000 shares0.043% mcap47.5% of flowOrdinary SharesSEC:0001178913-26-003473:0
- 15,740,000 shares52.5% of flowOrdinary SharesSEC:0001178913-26-002183:0
3 of 3 declarations